Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03680872 · ClinicalTrials.gov registry record · NA

Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System

A NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by Chad Bouton.

Recruiting
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT03680872 is a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical that is actively recruiting participants, run by Chad Bouton. The registered enrollment target is 7 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03680872, a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by Chad Bouton.

RECRUITING
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.

Interventions

  • DEVICE Bidirectional Neural Bypass System

Study Locations (1)

New York

  • Northwell Health's The Feinstein Institute for Medical Research - Manhasset

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2019-09-30
Est. Completion 2028-12
Phase NA

Sponsor

Chad Bouton

1 total trials

What the Registry Record Tells You About NCT03680872

The ClinicalTrials.gov registry entry for NCT03680872 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (89% lower). The listed sponsor is Chad Bouton, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Bidirectional Neural Bypass System is the first listed.

NCT03680872 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03680872 about?

NCT03680872 is a clinical study titled "Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System". This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.

What is the current status of trial NCT03680872?

This trial is currently recruiting. It is a NA study. The enrollment target is 7 participants. The study started on 2019-09-30. Estimated completion is 2028-12.

What conditions does trial NCT03680872 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical.

What interventions are being tested in trial NCT03680872?

The interventions under investigation include: Bidirectional Neural Bypass System (DEVICE).

Who is sponsoring clinical trial NCT03680872?

This trial is sponsored by Chad Bouton, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03680872 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.